Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression
ClinicalTrials.gov study NCT06289517. IPD Sharing: NO. Countries: 1. Publications: 1.
New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer
ClinicalTrials.gov study NCT05893368. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT06539559. IPD Sharing: YES. Countries: 1. Publications: 8.
Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma
ClinicalTrials.gov study NCT02120911. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of Neoadjuvant Treatment Based on Dual Blockade With Pertuzumab and the Trastuzumab Biosimilar CT-P6 (Herzuma®) in Early HER2-positive Breast Cancer in Routin
ClinicalTrials.gov study NCT06907082. IPD Sharing: NO. Countries: 1. Publications: 1.
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
ClinicalTrials.gov study NCT04595565. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Her2-positive Lung Cancer Treated With Dedicated Drug
ClinicalTrials.gov study NCT03845270. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)
ClinicalTrials.gov study NCT04858529. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT04605575. IPD Sharing: NO. Countries: 1. Publications: 3.
Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions
ClinicalTrials.gov study NCT03805841. IPD Sharing: NO. Countries: 3. Publications: 1.
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2
ClinicalTrials.gov study NCT04985266. IPD Sharing: Not stated. Countries: 2. Publications: 12.
Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients with RCR and PCR in the Breast After NAST
ClinicalTrials.gov study NCT04101851. IPD Sharing: NO. Countries: 4. Publications: 1.
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
ClinicalTrials.gov study NCT03161353. IPD Sharing: NO. Countries: 7. Publications: 4.
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
ClinicalTrials.gov study NCT03671330. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1)
ClinicalTrials.gov study NCT03988036. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma
ClinicalTrials.gov study NCT04365790. IPD Sharing: NO. Countries: 1. Publications: 7.
Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02263495. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer
ClinicalTrials.gov study NCT03515798. IPD Sharing: Not stated. Countries: 1. Publications: 71.
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
ClinicalTrials.gov study NCT06378242. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed
ClinicalTrials.gov study NCT05631795. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.